4th Generation Safety-engineered CAR T cells

CAR T cells (fourth generation safety-engineered) · Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4th Generation Safety-engineered CAR T cells, covering 2020-06-11 to 2020-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas [Phase 1, Phase 2]

See pricing